Considerations for assessing frail older adults requesting medical assistance in dying

In 2016, medical assistance in dying (MAiD) was decriminalized in Canada with the passage of Bill C-14. Under Bill C-14, competent adults with a serious and incurable condition in an advanced state of irreversible decline who were experiencing intolerable physical or psychological suffering and whos...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Canadian Medical Association journal (CMAJ) Jg. 194; H. 2; S. E51 - E53
Hauptverfasser: Engelhart, Sarah, Stall, Nathan M., Quinn, Kieran L.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Canada Elsevier Inc 17.01.2022
CMA Joule Inc
CMA Impact, Inc
CMA Impact Inc
Schlagworte:
ISSN:0820-3946, 1488-2329, 1488-2329
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In 2016, medical assistance in dying (MAiD) was decriminalized in Canada with the passage of Bill C-14. Under Bill C-14, competent adults with a serious and incurable condition in an advanced state of irreversible decline who were experiencing intolerable physical or psychological suffering and whose death was reasonably foreseeable could be eligible for MAiD. After its passage, legal challenges were brought before the Superior Court of Quebec, who ruled that the original legislation was too restrictive and in violation of the Canadian Charter of Rights and Freedoms. This led to the passage of Bill C-7 in Mar 2021, which amended Canada's criminal code to remove "reasonably foreseeable death" as an eligibility criterion, thus creating 2 distinct pathways for MAiD, where death either is or is not reasonably forseeable. One patient population likely to be affected by these changes is older adults considered to be frail. Clinicians should consider whether factors contributing to frailty are reversible when considering requests for MAiD. MAiD for those in whom death is not reasonably forseeable is subject to additional safeguards including a minimum 90-day period for assessing eligibility and mandatory assessment by a clinician with expertise in the patient's condition.
Bibliographie:SourceType-Scholarly Journals-1
ObjectType-Commentary-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:0820-3946
1488-2329
1488-2329
DOI:10.1503/cmaj.210729